Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lovedeep Gondara

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
British Journal of Cancer|November 18, 2016
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trialAndrew J Coldman, Lovedeep Gondara, Laurie W Smith, et al.
JAMA|July 5, 2018
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical TrialGina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, et al.
International Journal of Cancer|November 10, 2018
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trialDarrel A Cook, Mel Krajden, Adam R Brentnall, et al.
International Journal of Cancer|June 28, 2019
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screeningAndrew J Coldman, Dirk van Niekerk, Mel Krajden, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
British Journal of Cancer|November 18, 2016
Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trialAndrew J Coldman, Lovedeep Gondara, Laurie W Smith, et al.
JAMA|July 5, 2018
Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical TrialGina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, et al.
International Journal of Cancer|November 10, 2018
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trialDarrel A Cook, Mel Krajden, Adam R Brentnall, et al.
International Journal of Cancer|June 28, 2019
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screeningAndrew J Coldman, Dirk van Niekerk, Mel Krajden, et al.
Pageof 6